MktsMarkets

Guardant Health, Inc.
NASDAQ: GHKey statistics
GH News
Stories mentioning GH from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 301,665 | 281,266 | 265,196 | 232,088 | 203,471 | 201,814 | 191,476 | 177,235 |
| Cost of Goods Sold | 104,919 | 99,492 | 93,587 | 81,205 | 74,723 | 77,593 | 74,489 | 72,421 |
| Gross Profit | 196,746 | 181,774 | 171,609 | 150,883 | 128,748 | 124,221 | 116,987 | 104,814 |
| Operating Expenses | ||||||||
| Research & Development | 91,038 | 98,264 | 89,957 | 87,449 | 88,521 | 93,543 | 87,306 | 83,102 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (121,350) | (120,805) | (98,989) | (106,413) | (111,041) | (125,965) | (117,328) | (100,618) |
| Interest Income | 11,151 | 10,032 | 7,391 | 7,560 | 9,112 | 11,653 | 13,257 | 13,913 |
| Interest Expense | ||||||||
| Other Expense | (157.00) | (18,268) | (48.00) | (25.00) | 7,851 | 4,667 | (3,007) | (15,145) |
| Pretax Income | (111,703) | (130,221) | (92,589) | (99,861) | (94,869) | (110,290) | (107,724) | (102,495) |
| Tax Provision | 372.00 | (1,727) | 136.00 | 38.00 | 290.00 | 716.00 | 30.00 | 133.00 |
| Net Income (Loss) | (112,075) | (128,494) | (92,725) | (99,899) | (95,159) | (111,006) | (107,754) | (102,628) |
| Earnings Per Share (Basic) | (0.85) | (1.02) | (0.74) | (0.80) | (0.77) | (0.90) | (0.88) | (0.84) |
| Earnings Per Share (Diluted) | (0.85) | (1.02) | (0.74) | (0.80) | (0.77) | (0.90) | (0.88) | (0.84) |
| Weighted Average Shares Outstanding (Basic) | 131,273 | 125,374 | 124,807 | 124,114 | 123,871 | 122,745 | 123,051 | 122,447 |
| Weighted Average Shares Outstanding (Diluted) | 131,273 | 125,374 | 124,807 | 124,114 | 123,871 | 122,745 | 123,051 | 122,447 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About GH
Guardant Health, Inc. (NASDAQ: GH) is a stock listed on the Nasdaq Stock Market under the ticker symbol GH. It last traded at $145.59 (Nov 19, 2026, 4:00 PM ET), up 0.3% on the day. That gives Guardant Health a market capitalisation of $20.0B.
Over the past 52 weeks GH has traded between $74.55 and $191.05.
Revenue for the quarter ended Mar 31, 2026 was $301.7M; a net loss of $112.1M. Revenue was up 48.3% from $203.5M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $301.7M | -$112.1M | -37.2% |
| Dec 31, 2025 | $281.3M | -$128.5M | -45.7% |
| Sep 30, 2025 | $265.2M | -$92.7M | -35.0% |
| Jun 30, 2025 | $232.1M | -$99.9M | -43.0% |
From Guardant Health’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…